CTOs on the Move

Haven Health Ctr At Seacoast

www.seacoasthealth.com

 
Haven Health Ctr At Seacoast is a Hampton, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Blue Ridge Medical Imaging

Blue Ridge Medical Imaging is a Salem, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kansas City Internal Medicine

Kansas City Internal Medicine is a Kansas City, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medivators

Medivators, a wholly owned subsidiary of Cantel Medical Corp. (NYSE:CMN), is a leading provider of infection control products and services that ensure the safe and proper disinfection of endoscopes and other devices. Beyond the full line of Medivators medical device reprocessing systems, disinfectants, detergents and other supplies for endoscopy, Medivators also provides sterilants, dialysate concentrates and other supplies for renal dialysis, hollow fiber membrane filtration and separation technologies for medical and non medical applications and liquid chemical germicides and decontamination products and services used in other applications for infection prevention and control. Medivators new low-temperature sterilization service provides superior material compatibility over legacy sterilization methods. Medivators was founded in 1974 and publicly held since 1983 and employs approximately 400 people.

Hospice El Paso

Hospice El Paso, Inc. is a El Paso, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Metamark

Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.